{"id":"W2038751486","doi":"10.1158/1538-7445.am2014-103","title":"Abstract 103: 64-Cu-NOTA-panitumumab F(ab')2 fragments for PET/CT imaging of pancreatic cancer","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research; University of Toronto","funders":"","keywords":"Pancreatic cancer; Biodistribution; Cancer; Cancer research; Pancreas; Panitumumab; Radioimmunotherapy; Imaging agent; Epidermal growth factor receptor; Chemistry; Pathology; Medicine; Molecular biology; Nuclear medicine; Monoclonal antibody; Cetuximab; Internal medicine; Antibody; Biology; Colorectal cancer; Immunology; In vivo","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002919813,0.0004225339,0.0002796449,0.0003103476,0.0001470695,0.0004021483,0.0003386961,0.0006201515,0.003197844],"category_scores_gemma":[0.0001698907,0.0002359344,0.0001787501,0.0002547177,0.0001578174,0.0002694786,0.0001575328,0.0003796468,0.001100471],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004759815,"about_ca_system_score_gemma":0.0002443814,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009440716,"about_ca_topic_score_gemma":0.0007299828,"domain_scores_codex":[0.9998871,0.0000234394,0.000006359624,0.00003518547,0.00002674187,0.00002120299],"domain_scores_gemma":[0.9999472,0.00000838264,0.00001169888,0.000007300508,0.00001486717,0.00001056085],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0001897421,0.00002550726,0.0001664161,0.0001122782,0.00000858046,0.0001141923,0.0000111507,0.0001529618,0.9935685,0.0001281798,0.000512242,0.005010237],"study_design_scores_gemma":[0.00006123174,0.0003677385,0.002788535,0.00002893392,0.00003915125,0.001854984,0.00001549735,0.002855285,0.9759234,0.00005610876,0.01599804,0.00001116958],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8865137,0.0139365,0.07051958,0.0007434032,0.0002535278,0.0004760078,0.001426536,0.001714891,0.02441594],"genre_scores_gemma":[0.9430989,0.00292342,0.03732721,0.0003830029,0.00003627062,0.0002716333,0.002043371,0.0002309551,0.01368521],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003197844,"threshold_uncertainty_score":0.01069784,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1135385626504268,"score_gpt":0.4860589129321959,"score_spread":0.3725203502817691,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}